Home » OxyContin Maker Guards Exclusivity
OxyContin Maker Guards Exclusivity
OxyContin is set to go off patent next year, but the maker of the powerful and widely abused prescription painkiller is trying to extend its exclusive rights to the drug, arguing that a new version it spent $100 million to develop might substantially curtail abuse.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May